Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew C Nelson

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Cancers|September 26, 2020
Erratum: Witschen, P.M., et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. <i>Cancers</i> 2020, <i>12</i>, 1325Patrice M Witschen, Thomas S Chaffee, Nicholas J Brady, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2019
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factorsEmily A Irey, Chelsea M Lassiter, Nicholas J Brady, et al.
Cancers|August 29, 2024
Patients with <i>TP53</i>-Mutated Acute Myeloid Leukemia Receiving Intensive Induction Therapy Have Superior Outcomes Due to a Higher Rate of Salvage Therapy: A Single Institution, Retrospective StudyNuttavut Sumransub, Gabriel K Steinwand, Keith Cordner, et al.
The Journal of Biological Chemistry|May 13, 2020
<i>RAS</i> internal tandem duplication disrupts GTPase-activating protein (GAP) binding to activate oncogenic signalingAndrew C Nelson, Thomas J Turbyville, Srisathiyanarayanan Dharmaiah, et al.
Frontiers in Genetics|May 19, 2025
Validation of a comprehensive long-read sequencing platform for broad clinical genetic diagnosisSiddhartha Sen, Hillary P Handler, Alec Victorsen, et al.
Translational Oncology|December 23, 2021
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formationJianbo Yang, Qianjin Liao, Matthew Price, et al.
Iscience|October 7, 2025
SARS-CoV-2 infection drives local inflammation of the intestinal epithelium in immunocompromised patients with cancerEmil Lou, Christine Luo, Katherine Ladner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2025
Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial CancerBritt K Erickson, Howard Bailey, Rebecca C Arend, et al.
MMWR. Morbidity and Mortality Weekly Report|November 25, 2020
COVID-19 Outbreak Associated with a 10-Day Motorcycle Rally in a Neighboring State - Minnesota, August-September 2020Melanie J Firestone, Haley Wienkes, Jacob Garfin, et al.
Cancer Research|August 5, 2020
Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian CarcinomaLudwig Geistlinger, Sehyun Oh, Marcel Ramos, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Cancers|September 26, 2020
Erratum: Witschen, P.M., et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. <i>Cancers</i> 2020, <i>12</i>, 1325Patrice M Witschen, Thomas S Chaffee, Nicholas J Brady, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2019
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factorsEmily A Irey, Chelsea M Lassiter, Nicholas J Brady, et al.
Cancers|August 29, 2024
Patients with <i>TP53</i>-Mutated Acute Myeloid Leukemia Receiving Intensive Induction Therapy Have Superior Outcomes Due to a Higher Rate of Salvage Therapy: A Single Institution, Retrospective StudyNuttavut Sumransub, Gabriel K Steinwand, Keith Cordner, et al.
The Journal of Biological Chemistry|May 13, 2020
<i>RAS</i> internal tandem duplication disrupts GTPase-activating protein (GAP) binding to activate oncogenic signalingAndrew C Nelson, Thomas J Turbyville, Srisathiyanarayanan Dharmaiah, et al.
Frontiers in Genetics|May 19, 2025
Validation of a comprehensive long-read sequencing platform for broad clinical genetic diagnosisSiddhartha Sen, Hillary P Handler, Alec Victorsen, et al.
Translational Oncology|December 23, 2021
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formationJianbo Yang, Qianjin Liao, Matthew Price, et al.
Iscience|October 7, 2025
SARS-CoV-2 infection drives local inflammation of the intestinal epithelium in immunocompromised patients with cancerEmil Lou, Christine Luo, Katherine Ladner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2025
Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial CancerBritt K Erickson, Howard Bailey, Rebecca C Arend, et al.
MMWR. Morbidity and Mortality Weekly Report|November 25, 2020
COVID-19 Outbreak Associated with a 10-Day Motorcycle Rally in a Neighboring State - Minnesota, August-September 2020Melanie J Firestone, Haley Wienkes, Jacob Garfin, et al.
Cancer Research|August 5, 2020
Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian CarcinomaLudwig Geistlinger, Sehyun Oh, Marcel Ramos, et al.
Pageof 9